The compounds favorable safety profile, selective mechanism, and research-backed efficacy make it an attractive option for individuals seeking to optimize body composition, enhance metabolic health, and support healthy aging processes
Single or limited treatments rather than ongoing protocols
Potential concerns like hair loss with retatrutide and GLP-1 related fatigue have been reported and typically resolve with dose adjustment or stabilization at steady state
The first 72-week non-diabetic obesity dose is 5 mg weekly. The lowest measured human trial dose is 1 mg weekly in type 2 diabetes. Is 2.5 mg tirzepatide therapeutic
According to a study by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) titled Alcohol Facts and Statistics, 2023, 78.2% of people aged 18 and older reported drinking alcohol at some point in their lives, and 54.3% reported drinking in the past month
This simple blood test measures different types of fats in your bloodstream, including cholesterol and triglycerides